(COLM) Columbia Sportswear - Ratings and Ratios
Apparel, Footwear, Accessories, Equipment
Dividends
| Dividend Yield | 2.18% |
| Yield on Cost 5y | 1.48% |
| Yield CAGR 5y | 46.57% |
| Payout Consistency | 90.7% |
| Payout Ratio | 36.3% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 36.7% |
| Value at Risk 5%th | 59.1% |
| Relative Tail Risk | -2.15% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.01 |
| Alpha | -51.64 |
| CAGR/Max DD | -0.27 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.399 |
| Beta | 1.032 |
| Beta Downside | 0.886 |
| Drawdowns 3y | |
|---|---|
| Max DD | 47.49% |
| Mean DD | 20.29% |
| Median DD | 17.87% |
Description: COLM Columbia Sportswear November 09, 2025
Columbia Sportswear Company (NASDAQ: COLM) designs, develops, markets and distributes outdoor, active and lifestyle products across North America, Latin America, Europe, the Asia-Pacific, the Middle East and Africa. Its portfolio includes apparel, accessories and equipment for activities such as hiking, trail running, snow sports, fishing and hunting, as well as a broad footwear lineup ranging from technical hiking boots to casual lifestyle shoes.
The firm reaches consumers through two primary channels: a wholesale network of independent specialty stores, sporting-goods chains, department stores, internet retailers and international distributors; and a direct-to-consumer (DTC) network that comprises branded retail and outlet stores, temporary clearance locations, employee-only shops, brand-specific e-commerce sites and shop-in-shop concepts. Columbia markets its products under four brands: Columbia, Mountain Hardwear, prAna and SOREL.
Key recent metrics: FY 2023 revenue was approximately $4.6 billion, with a 12 % operating margin, and DTC sales grew about 15 % year-over-year, outpacing the slower-growing wholesale segment. The outdoor-apparel sector is being buoyed by rising consumer discretionary spending on recreation, yet remains sensitive to inflation-driven cost pressures and supply-chain disruptions.
For a deeper dive into Columbia’s valuation metrics and scenario analysis, you might find ValueRay’s interactive tools useful.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (186.6m TTM) > 0 and > 6% of Revenue (6% = 205.4m TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA -11.23pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 33.70% (prev 37.79%; Δ -4.10pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.09 (>3.0%) and CFO 234.2m > Net Income 186.6m (YES >=105%, WARN >=100%) |
| Net Debt (251.5m) to EBITDA (287.1m) ratio: 0.88 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.95 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (55.1m) change vs 12m ago -4.87% (target <= -2.0% for YES) |
| Gross Margin 50.40% (prev 50.02%; Δ 0.38pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 125.1% (prev 120.7%; Δ 4.41pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -12.93 (EBITDA TTM 287.1m / Interest Expense TTM -17.9m) >= 6 (WARN >= 3) |
Altman Z'' 7.07
| (A) 0.43 = (Total Current Assets 1.75b - Total Current Liabilities 592.7m) / Total Assets 2.71b |
| (B) 0.63 = Retained Earnings (Balance) 1.72b / Total Assets 2.71b |
| (C) 0.08 = EBIT TTM 231.2m / Avg Total Assets 2.74b |
| (D) 1.57 = Book Value of Equity 1.66b / Total Liabilities 1.06b |
| Total Rating: 7.07 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 59.89
| 1. Piotroski 6.0pt |
| 2. FCF Yield 5.45% |
| 3. FCF Margin 4.95% |
| 4. Debt/Equity 0.29 |
| 5. Debt/Ebitda 0.88 |
| 6. ROIC - WACC (= 1.46)% |
| 7. RoE 10.98% |
| 8. Rev. Trend -10.77% |
| 9. EPS Trend -28.08% |
What is the price of COLM shares?
Over the past week, the price has changed by -0.40%, over one month by +7.30%, over three months by -1.96% and over the past year by -37.99%.
Is COLM a buy, sell or hold?
- Strong Buy: 1
- Buy: 1
- Hold: 5
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the COLM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 57.6 | 4.5% |
| Analysts Target Price | 57.6 | 4.5% |
| ValueRay Target Price | 49.3 | -10.6% |
COLM Fundamental Data Overview November 26, 2025
P/E Trailing = 15.8036
P/E Forward = 18.1818
P/S = 0.8368
P/B = 1.7358
P/EG = 2.66
Beta = 0.921
Revenue TTM = 3.42b USD
EBIT TTM = 231.2m USD
EBITDA TTM = 287.1m USD
Long Term Debt = 480.3m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 82.7m USD (from shortTermDebt, last quarter)
Debt = 480.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 251.5m USD (from netDebt column, last quarter)
Enterprise Value = 3.11b USD (2.87b + Debt 480.3m - CCE 236.0m)
Interest Coverage Ratio = -12.93 (Ebit TTM 231.2m / Interest Expense TTM -17.9m)
FCF Yield = 5.45% (FCF TTM 169.5m / Enterprise Value 3.11b)
FCF Margin = 4.95% (FCF TTM 169.5m / Revenue TTM 3.42b)
Net Margin = 5.45% (Net Income TTM 186.6m / Revenue TTM 3.42b)
Gross Margin = 50.40% ((Revenue TTM 3.42b - Cost of Revenue TTM 1.70b) / Revenue TTM)
Gross Margin QoQ = 50.01% (prev 49.09%)
Tobins Q-Ratio = 1.15 (Enterprise Value 3.11b / Total Assets 2.71b)
Interest Expense / Debt = 0.86% (Interest Expense 4.13m / Debt 480.3m)
Taxrate = 26.74% (19.0m / 71.0m)
NOPAT = 169.4m (EBIT 231.2m * (1 - 26.74%))
Current Ratio = 2.95 (Total Current Assets 1.75b / Total Current Liabilities 592.7m)
Debt / Equity = 0.29 (Debt 480.3m / totalStockholderEquity, last quarter 1.66b)
Debt / EBITDA = 0.88 (Net Debt 251.5m / EBITDA 287.1m)
Debt / FCF = 1.48 (Net Debt 251.5m / FCF TTM 169.5m)
Total Stockholder Equity = 1.70b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.88% (Net Income 186.6m / Total Assets 2.71b)
RoE = 10.98% (Net Income TTM 186.6m / Total Stockholder Equity 1.70b)
RoCE = 10.61% (EBIT 231.2m / Capital Employed (Equity 1.70b + L.T.Debt 480.3m))
RoIC = 9.96% (NOPAT 169.4m / Invested Capital 1.70b)
WACC = 8.50% (E(2.87b)/V(3.35b) * Re(9.82%) + D(480.3m)/V(3.35b) * Rd(0.86%) * (1-Tc(0.27)))
Discount Rate = 9.82% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.43%
[DCF Debug] Terminal Value 62.87% ; FCFE base≈294.7m ; Y1≈193.5m ; Y5≈88.5m
Fair Price DCF = 24.69 (DCF Value 1.33b / Shares Outstanding 53.9m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -28.08 | EPS CAGR: -21.81% | SUE: -1.08 | # QB: 0
Revenue Correlation: -10.77 | Revenue CAGR: -4.69% | SUE: 1.57 | # QB: 2
EPS next Quarter (2026-03-31): EPS=0.57 | Chg30d=+0.092 | Revisions Net=+0 | Analysts=6
EPS next Year (2026-12-31): EPS=2.96 | Chg30d=-0.159 | Revisions Net=-3 | Growth EPS=-2.2% | Growth Revenue=+1.7%
Additional Sources for COLM Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle